CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-23 | Brenner Robert Chief Medical Officer | Sale | −2,151 | $41.98 | $90K | 50,947 |
| 2026-02-04 | Brenner Robert Chief Medical Officer | Grant or award | +25,000 | 53,098 | ||
| 2026-02-04 | Brenner Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-02-18 | Brenner Robert Chief Medical Officer | Grant or award | +26,900 | 27,474 | ||
| 2025-02-18 | Brenner Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +53,800 | 53,800 | ||
| 2024-01-03 | Brenner Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 |
Page 1 of 1 · 6 trades